Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Income towards Parent Company (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Income towards Parent Company for 16 consecutive years, with -$4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company rose 75.84% year-over-year to -$4.5 million, compared with a TTM value of -$94.4 million through Dec 2025, up 18.11%, and an annual FY2025 reading of -$94.4 million, up 18.11% over the prior year.
  • Income towards Parent Company was -$4.5 million for Q4 2025 at Orthofix Medical, up from -$22.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $16.1 million in Q4 2022 and bottomed at -$60.9 million in Q1 2023.
  • Average Income towards Parent Company over 5 years is -$19.4 million, with a median of -$20.3 million recorded in 2023.
  • The sharpest move saw Income towards Parent Company soared 163.55% in 2022, then crashed 1684.01% in 2023.
  • Year by year, Income towards Parent Company stood at -$25.3 million in 2021, then skyrocketed by 163.55% to $16.1 million in 2022, then plummeted by 237.89% to -$22.2 million in 2023, then grew by 16.71% to -$18.5 million in 2024, then surged by 75.84% to -$4.5 million in 2025.
  • Business Quant data shows Income towards Parent Company for OFIX at -$4.5 million in Q4 2025, -$22.8 million in Q3 2025, and -$14.1 million in Q2 2025.